Murray Maytom

Q: What is Murray C Maytom email address?

Email Murray C Maytom at mmaytom@lithera.com and murray.maytom@att.net. This email is the most updated Murray C Maytom's email found in 2026.

Q: How to contact Murray C Maytom?

To contact Murray C Maytom send an email to mmaytom@lithera.com or murray.maytom@att.net. (updated on September 02, 2024)

R&D Consultant at RAND bioPartners Inc. | San Diego, California, United States

About Murray Maytom

Dr. Murray C. Maytom is a seasoned R&D Consultant at RAND bioPartners Inc., where he leverages over two decades of extensive experience in the pharmaceutical industry, particularly in clinical development and medical affairs. His diverse expertise spans both the US and EU markets, allowing him to navigate complex regulatory landscapes and deliver tailored solutions for a variety of therapeutic areas. Since joining RAND bioPartners in July 2019, Dr. Maytom has been instrumental in driving key projects that underscore his commitment to advancing pharmaceutical innovation.

Currently, he provides clinical development support for a Phase 2 CNS start-up company, where his insights into clinical trial design and execution are pivotal in shaping the program's trajectory. Additionally, Dr. Maytom offers medical guidance and pharmacovigilance support for a Post Approval Phase 4 Psychiatry 505(b)(2) study, ensuring that safety and efficacy are rigorously monitored in real-world settings. His role as a Data Monitoring Committee (DMC) member for an Orphan Ophthalmology program further highlights his dedication to safeguarding patient welfare while facilitating the advancement of novel therapies.

Dr. Maytom's proficiency in medical writing and his comprehensive understanding of Good Clinical Practice (GCP) standards enhance his ability to communicate complex scientific concepts effectively. His background in dermatology and urology, combined with his strong foundation in pharmaceutics, positions him as a versatile consultant capable of addressing multifaceted challenges within the pharmaceutical landscape. Through his work at RAND bioPartners, Dr. Maytom continues to make significant contributions to the field, driving innovation and improving patient outcomes across a range of therapeutic domains.

Murray Maytom Work